1. Bray, F, Ferlay, J, Soerjomataram, I, et al: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68(6):394–424. http://doi.wiley.com/10.3322/caac.21492 (accessed 20 February 2020).
Google Scholar2. Haddad, AJ, Bani Hani, M, Pawlik, TM, et al: Colorectal liver metastases. Int J Surg Oncol 2011;2011:285840.
Google Scholar | Medline3. Xu, JM, Zhu, DX, Ren, L: [Surgical treatment of colorectal liver metastases]. Zhonghua Wai Ke Za Zhi 2017;55(7):491–495. http://www.ncbi.nlm.nih.gov/pubmed/28655075 (accessed 21 February 2020).
Google Scholar4. Robertson, DJ, Stukel, TA, Gottlieb, DJ, et al: Survival after hepatic resection of colorectal cancer metastases. Cancer 2009;115(4):752–759.
Google Scholar | Crossref | Medline5. Andres, A, Toso, C, Adam, R, et al: A survival analysis of the liver-first reversed management of advanced simultaneous colorectal liver metastases: A LiverMetSurvey-based study. Ann Surg 2012;256(5):772–778; discussion 778–779.
Google Scholar | Crossref | Medline6. Valdimarsson, VT, Syk, I, Lindell, G, et al: Outcomes of liver-first strategy and classical strategy for synchronous colorectal liver metastases in Sweden. HPB 2018;20(5):441–447.
Google Scholar | Crossref | Medline7. Kopetz, S, Chang, GJ, Overman, MJ, et al: Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 2009;27:3677–3683. www.jco.org (accessed 20 February 2020).
Google Scholar8. Mentha, G, Roth, AD, Terraz, S, et al: ‘Liver first’ approach in the treatment of colorectal cancer with synchronous liver metastases. Dig Surg 2008;25(6):430–435. https://www.karger.com/Article/FullText/184734
Google Scholar9. Esposito, F, Lim, C, Sa Cunha, A, et al: Primary tumor versus liver-first approach for synchronous colorectal liver metastases: An Association Francaise de Chirurgie (AFC) multicenter-based study with propensity score analysis. World J Surg 2018;42(12):4046–4053.
Google Scholar | Crossref | Medline10. Vallance, AE, van der Meulen, J, Kuryba, A, et al: The timing of liver resection in patients with colorectal cancer and synchronous liver metastases: A population-based study of current practice and survival. Colorectal Dis 2018;20(6):486–495.
Google Scholar | Crossref | Medline11. Grundmann, RT : Current state of surgical treatment of liver metastases from colorectal cancer. World J Gastrointest Surg 2011;3(12):183–196.
Google Scholar | Crossref | Medline12. Labori, KJ, Guren, MG, Brudvik, KW, et al: Resection of synchronous liver metastases between radiotherapy and definitive surgery for locally advanced rectal cancer: Short-term surgical outcomes, overall survival and recurrence-free survival. Colorectal Dis 2017;19(8):731–738. http://www.ncbi.nlm.nih.gov/pubmed/28181384 (accessed 17 January 2020).
Google Scholar13. Jegatheeswaran, S, Mason, JM, Hancock, HC, et al: The liver-first approach to the management of colorectal cancer with synchronous hepatic metastases: A systematic review. JAMA Surg 2013;148(4):385–391.
Google Scholar | Crossref | Medline14. Lam, VWT, Laurence, JM, Pang, T, et al: A systematic review of a liver-first approach in patients with colorectal cancer and synchronous colorectal liver metastases. HPB 2014;16(2):101–108.
Google Scholar | Crossref | Medline15. Kelly, ME, Spolverato, G, Le, GN, et al: Synchronous colorectal liver metastasis: A network meta-analysis review comparing classical, combined, and liver-first surgical strategies. J Surg Oncol 2015;111(3):341–351.
Google Scholar | Crossref | Medline16. Gavriilidis, P, Katsanos, K, Sutcliffe, RP, et al: Simultaneous, delayed and liver-first hepatic resections for synchronous colorectal liver metastases: A systematic review and network meta-analysis. J Clin Med Res 2019;11(8):572–582.
Google Scholar | Crossref | Medline17. Shamseer, L, Moher, D, Clarke, M, et al: Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: Elaboration and explanation. BMJ 2015;350:g7647.
Google Scholar | Crossref | Medline18. Stroup, DF, Berlin, JA, Morton, SC, et al: Meta-analysis of observational studies in epidemiology: A proposal for reporting. J Am Med Assoc 2000;283(15):2008–2012.
Google Scholar | Crossref | Medline | ISI19. Dindo, D, Demartines, N, Clavien, PA: Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240(2):205–213.
Google Scholar | Crossref | Medline | ISI20. Lim, C, Doussot, A, Osseis, M, et al: Primary tumor versus liver-first strategy in patients with stage IVA colorectal cancer: A propensity score analysis of long-term outcomes and recurrence pattern. Ann Surg Oncol 2016;23(9):3024–3032.
Google Scholar | Crossref | Medline21. Welsh, FKS, Chandrakumaran, K, John, TG, et al: Propensity score-matched outcomes analysis of the liver-first approach for synchronous colorectal liver metastases. Br J Surg 2016;103(5):600–606.
Google Scholar | Crossref | Medline22. de Rosa, A, Gomez, D, Hossaini, S, et al: Stage IV colorectal cancer: Outcomes following the liver-first approach. J Surg Oncol 2013;108(7):444–449.
Google Scholar | Crossref | Medline23. Wang, K, Liu, W, Yan, X-L, et al: Role of a liver-first approach for synchronous colorectal liver metastases. World J Gastroenterol 2016;22(6):2126–2132.
Google Scholar | Crossref | Medline24. Berardi, G, De Man, M, Laurent, S, et al: Radiologic and pathologic response to neoadjuvant chemotherapy predicts survival in patients undergoing the liver-first approach for synchronous colorectal liver metastases. Eur J Surg Oncol 2018;44(7):1069–1077.
Google Scholar | Crossref | Medline25. Tanaka, K, Murakami, T, Matsuo, K, et al: Preliminary results of “liver-first” reverse management for advanced and aggressive synchronous colorectal liver metastases: A propensity-matched analysis. Dig Surg 2015;32(1):16–22.
Google Scholar | Crossref | Medline26. Buchs, NC, Ris, F, Majno, PE, et al: Rectal outcomes after a liver-first treatment of patients with stage IV rectal cancer. Ann Surg Oncol 2015;22(3):931–937. http://www.ncbi.nlm.nih.gov/pubmed/25201505 (accessed 17 January 2020).
Google Scholar27. Verhoef, C, Van Der Pool, AEM, Nuyttens, JJ, et al: The “liver-first approach” for patients with locally advanced rectal cancer and synchronous liver metastases. Dis Colon Rectum 2009;52(1):23–30.
Google Scholar | Crossref | Medline28. Brouquet, A, Mortenson, MM, Vauthey, JN, et al: Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: Classic, combined or reverse strategy? J Am Coll Surg 2010;210(6):934–941.
Google Scholar | Crossref | Medline29. Kardassis, D, Ntinas, A, Miliaras, D, et al: Patients with multiple synchronous colonic cancer hepatic metastases benefit from enrolment in a “liver first” approach protocol. World J Hepatol 2014;6(7):513–519. http://www.ncbi.nlm.nih.gov/pubmed/25068003 (accessed 17 January 2020).
Google Scholar30. D’Hondt, M, Lucidi, V, Vermeiren, K, et al: The interval approach: An adaptation of the liver-first approach to treat synchronous liver metastases from rectal cancer. World J Surg Oncol 2017;15(1):54. http://www.ncbi.nlm.nih.gov/pubmed/28253875 (accessed 17 January 2020).
Google Scholar31. Salvador-Rosés, H, López-Ben Casellas-Robert, M, et al: Oncological strategies for locally advanced rectal cancer with synchronous liver metastases, interval strategy versus rectum first strategy: A comparison of short-term outcomes. Clin Transl Oncol 2018;20(8):1018–1025. http://www.ncbi.nlm.nih.gov/pubmed/29273957 (accessed 17 January 2020).
Google Scholar32. Ghiasloo, M, Kahya, H, Van Langenhove, S, et al: Effect of treatment sequence on survival in stage IV rectal cancer with synchronous and potentially resectable liver metastases. J Surg Oncol 2019;120(3):415–422.
Google Scholar | Crossref | Medline33. Nierop, PMH, Verseveld, M, Galjart, B, et al: The liver-first approach for locally advanced rectal cancer and synchronous liver metastases. Eur J Surg Oncol 2019;45(4):591–596.
Google Scholar | Crossref | Medline34. de Jong, MC, Beckers, RCJ, van Woerden, V, et al: The liver-first approach for synchronous colorectal liver metastases: More than a decade of experience in a single centre. HPB 2018;20(7):631–640.
Google Scholar | Crossref | Medline35. Eisenhauer, EA, Therasse, P, Bogaerts, J, et al: New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009;45(2):228–247.
Google Scholar | Crossref | Medline | ISI36. Slesser, AAP, Georgiou, P, Brown, G, et al: The tumour biology of synchronous and metachronous colorectal liver metastases: A systematic review. Clin Exp Metastasis 2013;30(4):457–470.
Google Scholar | Crossref | Medline37. Guest, RV, Søreide, K: Addressing the variation in hepatic surgery for colorectal liver metastasis. Hepatobiliary Surg Nutr 2021;10(1):103–106. https://hbsn.amegroups.com/article/view/41650/html (accessed 22 May 2021).
Google Scholar38. Ferrand, F, Malka, D, Bourredjem, A, et al: Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: Results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601. Eur J Cancer 2013;49(1):90–97.
Google Scholar | Crossref | Medline39. Adam, R, de Gramont, A, Figueras, J, et al: Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensus. Cancer Treat Rev 2015;41:729–741.
Google Scholar | Crossref | Medline | ISI40. Tsilimigras, DI, Ntanasis-Stathopoulos, I, Paredes, AZ, et al: Disappearing liver metastases: A systematic review of the current evidence. Surg Oncol 2019;29:7–13. http://www.ncbi.nlm.nih.gov/pubmed/31196496 (accessed 23 February 2020).
Google Scholar41. Hubert, C, Sempoux, C, Humblet, Y, et al: Sinusoidal obstruction syndrome (SOS) related to chemotherapy for colorectal liver metastases: Factors predictive of severe SOS lesions and protective effect of bevacizumab. HPB 2013;15(11):858–864.
Google Scholar | Crossref | Medline42. Hisaka, T, Ishikawa, H, Sakai, H, et al: Sinusoidal obstruction syndrome and postoperative complications resulting from preoperative chemotherapy for colorectal cancer liver metastasis. Anticancer Res 2019;39(8):4549–4554.
Google Scholar | Crossref | Medline43. Jafari, A, Wehner, S, Kalff, JC, et al: Sinusoidal obstruction syndrome in the animal model: Influence on liver surgery. Langenbecks Arch Surg 2017;402(1):115–122.
Google Scholar | Crossref | Medline44. Brudvik, KW, Jones, RP, Giuliante, F, et al: RAS mutation clinical risk score to predict survival after resection of colorectal liver metastases. Ann Surg 2019;269(1):120–126.
Google Scholar | Crossref | Medline45. Torén, W, Ansari, D, Andersson, R: Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases: A systematic review and meta-analysis. Cancer Cell Int 2018;18:217. http://www.ncbi.nlm.nih.gov/pubmed/30602942 (accessed 23 February 2020).
Google Scholar